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oAs a response to the meta-analysis: ‘‘Screening for
abdominal aortic aneurysm reduces overall mortality in
men. A meta-analysis of the mid- and long-term effects
of screening for abdominal aortic aneurysms’’, we are
grateful for Professor Lederle’s insightful observation
that the significant finding concerning overall mortality
was caused by an age imbalance in the West Australian
(WA) study. Due to a problem in the first year of
randomisation (1996), there were indeed more old men
in the control group of this study, and consequently
more deaths. The optimal way to clarify this would be
a merged dataset allowing proper survival analysis withDOI of original articles: 10.1016/j.ejvs.2008.07.011; 10.1016/
j.ejvs.2008.03.006.
622 Correspondenceadjustment for age, but this is unfortunately not
possible. Consequently, we resolved to use WA data for
men aged 65e74 years only (age matching being satis-
factory for this sub-group). All studies except the
Chichester study, which recruited up to the age of 80
years, have small risk reductions in overall mortality
favouring screening; the revised midterm 5 year results
showed no sign of heterogeneity, and the OR in a fixed
model was 0.97 (95% C.I.: 0.93; 1.00). In the long term
analysis, this 3% reduction was unchanged but now
became a statistical significant reduction (Fig. 1). Conse-
quently, this updated review produces robust evidence
of screening for AAA reduces overall mortality signifi-
cantly in the long term. In addition the result is very in-
teresting, as a 3% overall mortality risk reduction is
more than what would be expected by an approximately50% AAA-specific mortality risk reduction of a disease
causing 1½e2(3)% of all deaths among men aged 65 or
more.J.S. Lindholt*
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